Cargando…

A VSV-based Zika virus vaccine protects mice from lethal challenge

Infection with Zika virus (ZIKV) is commonly mild in humans but has been associated with alarming negative health outcomes including Guillain-Barré syndrome in adults and microcephaly in fetuses. As such, developing a vaccine for ZIKV is a global public health priority. Recombinant vesicular stomati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emanuel, Jackson, Callison, Julie, Dowd, Kimberly A., Pierson, Theodore C., Feldmann, Heinz, Marzi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056530/ https://www.ncbi.nlm.nih.gov/pubmed/30038228 http://dx.doi.org/10.1038/s41598-018-29401-x

Ejemplares similares

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019)

Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice
por: Marzi, Andrea, et al.
Publicado: (2018)

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021)

A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus
por: Bhatia, Bharti, et al.
Publicado: (2021)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
por: Jagger, Brett W, et al.
Publicado: (2019)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
por: Baldwin, Whitney R., et al.
Publicado: (2018)

Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis
por: Fensterl, Volker, et al.
Publicado: (2012)

Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge
por: Sorvillo, Teresa E., et al.
Publicado: (2021)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
por: Zivcec, Marko, et al.
Publicado: (2018)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR(-/-) mice
por: Bhatia, Bharti, et al.
Publicado: (2021)

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
por: Domi, Arban, et al.
Publicado: (2018)

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection
por: Fletcher, Paige, et al.
Publicado: (2023)

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
por: Brault, Aaron C., et al.
Publicado: (2017)

Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge
por: Leventhal, Shanna S., et al.
Publicado: (2022)

Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge
por: Espinosa, Diego, et al.
Publicado: (2017)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
por: Marzi, Andrea, et al.
Publicado: (2023)

Optimization of single dose VSV-based COVID-19 vaccination in hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
por: Qiu, Xiangguo, et al.
Publicado: (2009)

Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses
por: Goo, Leslie, et al.
Publicado: (2016)

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
por: Bollman, Brooke, et al.
Publicado: (2023)

Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters
por: Falzarano, Darryl, et al.
Publicado: (2015)

Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge
por: De Lorenzo, Giuditta, et al.
Publicado: (2020)

A single dose of recombinant VSV-RABV(G) vaccine provides full protection against RABV challenge
por: Liang, Minglong, et al.
Publicado: (2022)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge
por: Pattnaik, Aryamav, et al.
Publicado: (2023)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020)

Characterization of Lethal Zika Virus Infection in AG129 Mice
por: Aliota, Matthew T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uf6jhksuq7vbmkur394r2hc8f2